Bipolar disorder is otherwise called as maniac-depressive illness. The...Hence extensive research was done on this disease to identify the ...The research was collaborative effort from both the Garvan Institu...Dr. Ian Blair published his work in the journal molecular psychiat...At the end they found that the gene responsible to increase the ri...
Bipolar disorder is otherwise called as maniac-depressive illness. The disease incidence is about one in fifty. But the sad state is that one in six people who suffer from the disorder are likely to commit suicide.//
Hence extensive research was done on this disease to identify the gene and also develop various treatment modalities. Dr. Ian Blair conducted a study which revealed the bipolar risk gene.
The research was collaborative effort from both the Garvan Institute of Medical Research and University of New South Wales. This research would help many patients suffering from this disorder as it shows that certain people who have this gene are at a higher risk of developing Bipolar disorder.
Dr. Ian Blair published his work in the journal molecular psychiatry. They studied a wide rage of people including unrelated patients, and therapeutic drug mouse models and a large number of samples.
At the end they found that the gene responsible to increase the risk of this disorder to be the FAT gene. It codes for proteins which connect the brain cells.
But the exact mechanism of how the gene (FAT) increases the risk of developing bipolar disorder is still a mystery which has to be unraveled by conducting further research.
The treatment of this disorder is usually lithium. Lithium is apparently the first mood-stabilizing agent approved by the U.S. Food and Drug Administration (FDA).
But the mode of action of lithium is not yet understood in detail. Lithium also has few disadvantages like weight gain, kidney problems, tremor etc.
Dr Blair’s reports that lithium alters the FAT gene and its expression along with the other FAT proteins associated in increasing the risk of bipolar disorder.
In conclusion the scientist tells that further research is necessary to identify the mode of action of the FAT gene and develop new medicines that have no side-effects as lithium.
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
(Date:12/4/2009)KANSAS CITY, Mo., Dec. 4 The large, two-day free health clinic sponsored by the National Association of Free Clinics (NAFC) in Kansas City on Wednesday and Thursday is not just for the sick but also
(Date:12/4/2009)WASHINGTON, Dec. 4 While Congress debates whether health care reform would control health care costs, Leapfrog,s purchaser members point to 45 hospitals that lead through example -- delivering the be
(Date:12/4/2009)STANFORD, Calif. A new study shows that muscle cells grown in the lab can restore an intestine,s ability to squeeze shut properly. The work, performed in dogs and rats, might ultimately help treat pa
(Date:12/4/2009)More than 15 million Americans are recruited annually to participate in clinical trials according to the Alliance for Human Research Protection (AHRP), and most will be compensated for their participa
... care visits to family doctors are declining, rese...Day News) -- Specialists are increasingly providin...ionally been handled by primary care doctors, a ne... visits for specialized care is for routine and pr...
... Workman proudly touts support of Sam Schmidt Para... While Punch Energy Drink,s well-recognized tagli...orkman, Punch Energy Founder and 21-year-old bever...oday, Workman proudly announced that the Sam Schmi...
...leadership needed to manage growth , , WAYNE, Pa....f clinical documentation software, workflow tools ...and realigning its organization by service and sol...ion Services and James Stewart, Vice President of ...
..., March 10 More physician leaders are embracing t...records, but most still consider them clunky and u...ults found in a recent survey by the American Coll... management. , , ACPE conducted the same survey b...
... March 10 LCA-Vision Inc. (Nasdaq: LCAV ) today...arison of excimer laser platform technologies, the...of platforms at each of its Lasik Plus (R) vision ...ly no later than the end of the third quarter of 2...
...arch 10, 2009 Forest Laboratories, Inc. (NYSE: ...rma GmbH & Co. KGaA, and Merz Pharmaceuticals ...emark Office has issued a Notice of Final Determin... Administration Orange Book for NAMENDA(R) (memant...
(Date:12/3/2009)MADISON, N.J., Dec. 3 A genetic variation that may indicate a patient,s risk of developing a potentially life-threatening blood disorder if exposed to certain pharmaceutical therapies or chemicals is
(Date:12/3/2009)DOYLESTOWN, Pa., Dec. 3 Ted Karkus, Chairman and CEO of The Quigley Corporation, (Nasdaq: QGLY ) www.quigleyco.com announced today that the Company has completed its evaluation of its opportunitie
(Date:12/3/2009)WARRENDALE, Pa., Dec. 3 Radiology imaging leader MEDRAD, Inc. demonstrated PACS* injection-record integration capabilities at the November 2009 Radiology Society of North America in Chicago. The Co
...S, Oct. 26 The complex cases performed,during thi... Therapeutics,symposium by Dr. Tony Das, an interv...Dallas, represent the latest treatments for periph... the U.S. population ages and more,Americans live ... will also,dramatically increase the number of peo...
...SLEY, Mass., Oct. 26 Coley,Pharmaceutical Group, ...mpany,has received a $3.0 million milestone paymen...nitiation of GSK,s Phase III clinical trial in,non...eutic cancer vaccine,containing Coley,s VaxImmune(... the launch of the largest Phase III,clinical tria...
...nalyzer is a semi-automated benchtop instrument fo...nQuick is designed to analyze and generate results...k 8+ urine test strips. The UrinQuick analyzes the...y. Test results are available in conventional, S.I...